data13F

CRVS – Corvus Pharmaceuticals Inc

Held by 1 of 60 tracked investors in their latest 13F filing · 0 counted on Most owned (narrow-view filings excluded)

Investors holding1
Combined shares48,984
Combined reported value$564K

CRVS chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
Paul Tudor Jones narrow view 0.00 Added 122.7%48,984$564KQ3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Paul Tudor Jones narrow view Added 122.7%48,9840.00
Q2 2026Paul Tudor Jones narrow view Reduced 20.0%21,9920.00
Q1 2026Paul Tudor Jones narrow view New27,4940.00

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Paul Tudor Jones narrow view Added 122.7%48,9840.00
Q1 2026Paul Tudor Jones narrow view New27,4940.00

Reduced: reduced or closed

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q2 2026Paul Tudor Jones narrow view Reduced 20.0%21,9920.00

History

1 peakQ3 2026: 1 tracked investors
Q1 2016: 1 tracked investorsQ1 2026: 1 tracked investorsQ2 2026: 1 tracked investorsQ3 2026: 1 tracked investors
20162026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Paul Tudor Jones49.0K22.0K27.5K–––––

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).